BioNTech, Pfizer Say They Didn't Infringe CureVac Patents

By Hailey Konnath · July 25, 2022, 10:54 PM EDT

BioNTech and Pfizer on Monday asked a Massachusetts federal court to find that they haven't infringed CureVac patents related to COVID-19 vaccine technology, claiming that the drugmakers are facing threats of...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

BioNTech SE et al v. CureVac AG

Case Number

Court

Massachusetts

Nature of Suit

Patent

Date Filed

July 25, 2022

Recent Articles By Hailey

November 14, 2024
Ex-Ga. Rep. Doug Collins To Head Trump's Veterans Affairs
November 12, 2024
Trump Taps Elon Musk To Head New 'Gov't Efficiency' Dept.
November 04, 2024
Kroger, State AGs Finalize Sprawling $1.37B Opioid Deal
October 24, 2024
McDonald's Customers File First Suits Over E. Coli Outbreak
October 23, 2024
TriZetto Gets New Damages Trial After Ax Of $200M Awards
October 21, 2024
Google, Meta Want Out Of GoodRx Health Data Sharing Suit
October 18, 2024
HHS Slams Hackensack Meridian's Chevron-Inspired Suit
October 08, 2024
Cedars-Sinai OB-GYN Accused Of Abusing, Harassing Patients
October 08, 2024
Apple Loses Bid For Jury Trial In Masimo Trade Secrets Fight
October 07, 2024
Mednax Gets Final OK For $6M Data Breach Settlement